Coronary Disease
The patient was a 67-year-old man who was referred for surgical revascularization of coronary artery disease. Three months earlier, he had undergone emergency percutaneous coronary intervention (PCI) to the right coronary artery. He had a...
In this 27-year single-center retrospective study, the authors compared radial artery (RA) vs saphenous vein graft (SVG) as the third conduit in patients receiving bilateral internal mammary arteries (BIMA) for...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with James Cox, Professor of Cardiac Surgery at the Feinberg School of Medicine at Northwestern Medicine in Chicago, Illinois, USA,...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Taj Mohammed Fiyaz Chowdhry, a consultant thoracic surgeon at Burjeel Specialty Hospital, Sharjah, UAE, about uniportal robotics in the...
This single-center retrospective study examined 418 intent-to-treat hybrid coronary revascularization (HCR) patients undergoing robotic beating-heart totally endoscopic coronary artery bypass (TECAB) from 2013 to 2025, comparing those who completed planned...
This scientific statement is a granular contribution to a major cardiovascular issue, illuminating nuances of the “generally recognized as safe” (GRAS) FDA designation. One would expect the relevant Thoracic Associations...
This 10-year follow-up of the ROBY study reports on the primary end points of all-cause death and the composite of death or revascularization among 2203 patients randomized to off-pump or...
The rising burden of CAD in low- and middle-income countries like Nigeria is a result of the epidemiological transition from communicable to non- communicable diseases. The system of care for...
On December 9, the American Heart Association (AHA) and American College of Cardiology (ACC) jointly released a clinical practice guideline for coronary artery revascularization in patients with coronary artery disease....
A good-size Terumo-sponsored RCT that is set to impact on decisions to discontinue DAPT early after PCI with absorbable stent, a change that will somehow decrease the surgical risk of...
A large randomised double-blinded trial reporting a considerable benefit ( 0.79 HR with very small p and supporting confidence intervals) of the Boehringer SGLPT-2 inhibitor regardless of presence of formal...
An editorial that may herald the decrease in aspirinization and the rise of ticagrelor monotherapy in Percutaneous stenting of coronary arteries. There might be a peripheral relevance to the group...
An ad hoc interim analysis pursuant to previous publications raising concerns on Paclitaxel DCS in chronic critical and not-critical lower limb ischaemia. The short manuscript requires careful reading to form...

